-
Featured
Update on the Use of Human Antibody Bamlanivimab to Treat COVID-19: Q&A with Michael Dougan, MD, PhD
In this Q&A, Michael Dougan, MD, explains the interim results of the bamlanivimab clinical trial based on his experience with the trial at Massachusetts General Hospital, what has been learned about the therapy to date and what still needs to be studied for this drug to become a standard of care to treat COVID-19.
-
Featured
COVID-19 Vaccine Candidates
The effort to produce and distribute a SARS-CoV-2 vaccine has made remarkable progress. Currently there are over 180 candidate vaccines against SARS-CoV-2 in development worldwide.
-
Featured
Athletes and COVID-19: Q&A with Sports Cardiologist Meagan Wasfy, MD
The Cardiovascular Performance Program has been treating athletes diagnosed with COVID-19, ranging from those who are asymptomatic to those with persistent symptoms after their infection. Meagan Wasfy, MD, describes the evolution of return-to-play guidelines as we learn about the progression and treatment of COVID-19.
-
Translation App Streamlines Imaging Exams During COVID-19 Pandemic
The app is the product of a collaboration between the Radiology Diversity, Equity and Inclusion Committee and an in-house prototyping and entrepreneurship center at Massachusetts General Hospital.
-
Diagnostic Algorithm Supports Evaluation of Hospitalized COVID-19 Patients After Initial Negative Test
Researchers at Massachusetts General Hospital have developed the Covid Risk cALculator (CORAL), a diagnostic algorithm and clinical decision support system for evaluating hospitalized adults under investigation for COVID-19 who have had at least one negative SARS-CoV-2 nucleic acid amplification test (NAAT).
-
COVID-19 Patients with Rheumatic and Musculoskeletal Diseases at Substantial Risk of Poor Outcomes
Clinicians in the Division of Rheumatology, Allergy and Immunology found that for patients with rheumatic and musculoskeletal diseases who develop COVID-19, the risks of death and other severe outcomes have declined since early in the pandemic but remain considerable.
COVID-19 contributors
-
Boris D. Juelg, MD, PhD
Attending Physician, Division of Infectious Diseases, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Favipiravir to Treat COVID-19: Q&A with Boris Juelg, MD, PhD
-
Bryan Hayes, PharmD, DABAT, FAACT, FASHP
Assistant Professor of Emergency Medicine, Harvard Medical School, Senior Attending Pharmacist, Emergency Medicine and Toxicology, Massachusetts General Hospital
Recent Article
The Use of NSAIDs in COVID-19 Patients: Q&A with Bryan D. Hayes, PharmD -
Charles Corey Hardin, MD, PhD
Physician, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Associate Professor of Medicine, Harvard Medical School, Physician Investigator, Pulmonary, Mass General Research Institute
Recent Article
Editorial: Prone Positioning "Smooths the Edges" of Lung Protection During PEEP
-
Elizabeth Louise Hohmann, MD
Staff Physician, Infectious Diseases Division, Massachusetts General Hospital, Chair and Physician Director, Partners Human Research Committees
Recent Article
Encapsulated Fecal Microbiota Transplantation Alters Gut Microbiome in Adults with Obesity -
Elizabeth M. Van Cott, MD
Director, Coagulation Laboratory, Massachusetts General Hospital, Professor of Pathology, Harvard Medical School
Recent Article
Pronounced Elevation of Factor V in Severe COVID-19 Is Associated with Venous Thromboembolism -
Erica Seiguer Shenoy, MD, PhD
Associate Physician, Massachusetts General Hospital, Associate Chief of the Infection Control Unit, Massachusetts General Hospital
Recent Article
Diagnostic Algorithm Supports Evaluation of Hospitalized COVID-19 Patients After Initial Negative Test
-
Galit Alter, PhD
Principal Investigator, Ragon Institute, Massachusetts General Hospital, Samana Cay MGH Research Scholar
Recent Article
Monoclonal Antibodies for COVID-19 Need to Be "Tuned" to the Immune System
-
George A. Alba, MD
Pulmonary and Critical Care Physician, Instructor of Medicine at Harvard Medical School
Recent Article
The CORE Clinic and Post-ICU Care: Q&A with Leo Ginns, MD, and George Alba, MD
-
Hanny Al-Samkari, MD
Hematologist
Recent Article
Prothrombin Fragment 1.2 Predicts Thrombosis in Hospitalized Patients with COVID-19
-
Ilona T. Goldfarb, MD
Maternal Fetal Medicine Specialist
Recent Article
Outpatient Tracking and Telehealth for Pregnant Women with Symptomatic COVID-19
-
Katrina A. Armstrong, MD
Physician-in-Chief, Department of Medicine, Massachusetts General Hospital
Recent Article
Medical Grand Rounds: Evolution of the COVID-19 Pandemic: Implications for Vaccines, Treatment
-
Lorenzo Berra, MD
Medical Director, Respiratory Care, Massachusetts General Hospital
Recent Article
Case Series: Inhaled Nitric Oxide as Rescue Therapy for Nonintubated Patients with Severe COVID-19
-
Louise C. Ivers, MD
Interim Director of the Division of Infectious Diseases, Executive Director of the Mass General Center for Global Health
-
Michael L. Dougan, MD, PhD
Physician, Division of Gastroenterology, Massachusetts General Hospital, Director, GI Center for Cancer Complications, Mass General Cancer Center, Assistant Professor of Medicine, Harvard Medical School
Recent Article
Update on the Use of Human Antibody Bamlanivimab to Treat COVID-19: Q&A with Michael Dougan, MD, PhD
-
Rachel P. Rosovsky, MD
Hematologist, PERT Executive Committee Member
Recent Article
Prothrombin Fragment 1.2 Predicts Thrombosis in Hospitalized Patients with COVID-19
-
Raghu Chivukula, MD, PhD
Physician-Scientist, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital
Recent Article
Review: Evidence-Based Management of the Critically Ill Adult with COVID-19
Pulmonary and Critical Care Medicine
The Division of Pulmonary and Critical Care Medicine at Massachusetts General Hospital provides comprehensive care for the full range of respiratory conditions and diseases.Related Links
